BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38373964)

  • 1. Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy.
    Sun J; Zhang C; Su X; Zhou H; Zhou S; Jiang M; Fang B
    J Orthop Surg Res; 2024 Feb; 19(1):147. PubMed ID: 38373964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of patient compliance on the outcomes in hypertensive patients receiving hydrochlorothiazide based combination therapy with spironolactone or captopril].
    WU SL; DU X; XING AJ; SONG SM; HOU GS; YU Q; LIU FS; WANG GL; WANG LG; LI DX; CAO ZX; QI RP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1078-82. PubMed ID: 19134274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
    Liao YQ; Fang BB; Wu QX; Dong WY; Deng GM
    J Recept Signal Transduct Res; 2023 Aug; 43(4):93-101. PubMed ID: 38070127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
    Neutel JM; Smith D
    J Int Med Res; 2005; 33(6):620-31. PubMed ID: 16372579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
    Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
    Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
    Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.
    Shiga Y; Miura S; Norimatsu K; Hitaka Y; Nagata I; Koyoshi R; Morii J; Kuwano T; Uehara Y; Inoue A; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1078-84. PubMed ID: 25143336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
    Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
    J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
    Agabiti-Rosei E; Manolis A; Zava D; Omboni S;
    Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments].
    Santucci A; De Cesaris R; Buoninconti R; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):149-53. PubMed ID: 2678308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicentre, double-blind study.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Cagli V; Carotti A; Corea L; Innocenti P; Malerba M; Paciaroni E; Pirrelli A
    J Hypertens Suppl; 1987 Dec; 5(5):S599-602. PubMed ID: 3327931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
    Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of combination therapy with losartan and hydrochlorothiazide in elderly hypertension].
    Eto K; Tsuchihashi T; Abe I; Iida M
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):181-6. PubMed ID: 11974942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
    Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.
    Tedesco MA; Ratti G; Mennella S; Manzo G; Grieco M; Rainone AC; Iarussi D; Iacono A
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1130-4. PubMed ID: 10604491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.